ROCHE FINANCE LTD 13D and 13G filings for Entrada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:12 pm Sale | 2023-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | ROCHE FINANCE LTD | 2,744,120 8.200% | -69,405 (-2.47%) | Filing |
| 2022-02-14 06:19 am Purchase | 2021-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | ROCHE FINANCE LTD | 2,813,525 9.000% | 2,813,525 (New Position) | Filing |